Melatonin MT1 receptors regulate the Sirt1/Nrf2/Ho‐1/Gpx4 pathway to prevent α‐synuclein‐induced ferroptosis in Parkinson's disease
Journal of Pineal Research · 2024-03 · 76 (2)
DOI: 10.1111/jpi.12948 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pineal Research, online erschienen am 15.03.2024. Verfasst von Qian-Kun Lv und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Parkinson Disease, Melatonin, Ferroptosis. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Postgraduate Research & Practice Innovation Program of Jiangsu Province, Suzhou Technology Development Program, Jiangsu Provincial Key R&D Program.
Abstract (Originalsprache)
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic (DA) neurons and aggregation of α‐synuclein (α‐syn). Ferroptosis, a form of cell death induced by iron accumulation and lipid peroxidation, is involved in the pathogenesis of PD. It is unknown whether melatonin receptor 1 (MT1) modulates α‐syn and ferroptosis in PD. Here, we used α‐syn preformed fibrils (PFFs) to induce PD models in vivo and in vitro. In PD mice, α‐syn aggregation led to increased iron deposition and ferroptosis. MT1 knockout exacerbated these changes and resulted in more DA neuronal loss and severe motor impairment. MT1 knockout also suppressed the Sirt1/Nrf2/Ho1/Gpx4 pathway, reducing resistance to ferroptosis, and inhibited expression of ferritin Fth1, leading to more release of ferrous ions. In vitro experiments confirmed these findings. Knockdown of MT1 enhanced α‐syn PFF‐induced intracellular α‐syn aggregation and suppressed expression of the Sirt1/Nrf2/Ho1/Gpx4 pathway and Fth1 protein, thereby aggravating ferroptosis. Conversely, overexpression of MT1 reversed these effects. Our findings reveal a novel mechanism by which MT1 activation prevents α‐syn‐induced ferroptosis in PD, highlighting the neuroprotective role of MT1 in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, China.
Förderung
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- Suzhou Technology Development Program
- Jiangsu Provincial Key R&D Program
- Jiangsu Provincial Medical Key Discipline
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
Zitieren
APA
Lv, Q. K., Tao, K. X., Yao, X. Y., Pang, M. Z., Cao, B. E., Liu, C. F., & Wang, F. (2024). Melatonin MT1 receptors regulate the Sirt1/Nrf2/Ho‐1/Gpx4 pathway to prevent α‐synuclein‐induced ferroptosis in Parkinson's disease. Journal of Pineal Research, 76(2). https://doi.org/10.1111/jpi.12948
Vancouver
Lv QK, Tao KX, Yao XY, Pang MZ, Cao BE, Liu CF, et al. Melatonin MT1 receptors regulate the Sirt1/Nrf2/Ho‐1/Gpx4 pathway to prevent α‐synuclein‐induced ferroptosis in Parkinson's disease. Journal of Pineal Research. 2024;76(2). doi:10.1111/jpi.12948
BibTeX
@article{Lv2024,
author = {Lv, Qian-Kun and Tao, Kang-Xin and Yao, Xiao-Yu and Pang, Meng-Zhu and Cao, Bing-Er and Liu, Chun-Feng and Wang, Fen},
title = {Melatonin MT1 receptors regulate the Sirt1/Nrf2/Ho‐1/Gpx4 pathway to prevent α‐synuclein‐induced ferroptosis in Parkinson's disease},
journal = {Journal of Pineal Research},
year = {2024},
volume = {76},
number = {2},
doi = {10.1111/jpi.12948}
}
EUVIMED